What is the current valuation of the US diabetes devices market as of 2024?

The US diabetes devices market was valued at $9.2 Billion in 2024. Read More

What is the projected market valuation for the US diabetes devices market in 2035?

The market is projected to reach $19.4 Billion by 2035. Read More

What is the expected CAGR for the US diabetes devices market during the forecast period 2025 - 2035?

The expected CAGR for the market during 2025 - 2035 is 7.02%. Read More

Which segment of diabetes devices had the highest valuation in 2024?

In 2024, Insulin Delivery Devices had the highest valuation at $3.0 Billion. Read More

What is the projected valuation for Continuous Glucose Monitoring Systems by 2035?

The projected valuation for Continuous Glucose Monitoring Systems is $4.0 Billion by 2035. Read More

Which end user segment is expected to grow the most by 2035?

The Homecare segment is expected to grow significantly, reaching $7.46 Billion by 2035. Read More

What are the key players in the US diabetes devices market?

Key players include Medtronic, Abbott, Roche, Dexcom, and Insulet. Read More

How does the market for Type 2 Diabetes devices compare to Type 1 Diabetes devices in 2024?

In 2024, the market for Type 2 Diabetes devices was valued at $5.52 Billion, significantly higher than the $1.84 Billion for Type 1 Diabetes. Read More

What distribution channel is projected to have the highest growth by 2035?

Retail Pharmacies are projected to have the highest growth, reaching $7.46 Billion by 2035. Read More

What is the valuation range for Diabetes Management Software from 2024 to 2035?

The valuation for Diabetes Management Software is expected to grow from $1.7 Billion in 2024 to $4.4 Billion by 2035. Read More

US Diabetes Devices Market

ID: MRFR/HC/13144-HCR

100 Pages

Vikita Thakur

Last Updated: April 06, 2026

US Diabetes Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Blood Glucose Monitors, Insulin Delivery Devices, Continuous Glucose Monitoring Systems, Diabetes Management Software), By End Users (Hospitals, Homecare, Diabetes Clinics, Ambulatory Surgical Centers), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Direct Sales) and By Applications (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Device Type (USD Billion)
  1. 4.1.1 Blood Glucose Monitors
  2. 4.1.2 Insulin Delivery Devices
  3. 4.1.3 Continuous Glucose Monitoring Systems
  4. 4.1.4 Diabetes Management Software
2. 4.2 Chemicals and Materials, BY End User (USD Billion)
  1. 4.2.1 Hospitals
  2. 4.2.2 Homecare
  3. 4.2.3 Diabetes Clinics
  4. 4.2.4 Ambulatory Surgical Centers
3. 4.3 Chemicals and Materials, BY Distribution Channel (USD Billion)
  1. 4.3.1 Online Pharmacies
  2. 4.3.2 Retail Pharmacies
  3. 4.3.3 Hospital Pharmacies
  4. 4.3.4 Direct Sales
4. 4.4 Chemicals and Materials, BY Application (USD Billion)
  1. 4.4.1 Type 1 Diabetes
  2. 4.4.2 Type 2 Diabetes
  3. 4.4.3 Gestational Diabetes
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Abbott (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Roche (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Dexcom (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Boehringer Ingelheim (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Insulet (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Novo Nordisk (DK)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Sanofi (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Johnson & Johnson (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY DEVICE TYPE
3. 6.3 US MARKET ANALYSIS BY END USER
4. 6.4 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
5. 6.5 US MARKET ANALYSIS BY APPLICATION
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY DEVICE TYPE, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
14. 6.14 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Billion)
16. 6.16 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
18. 6.18 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Device Type (USD Billion, 2025-2035)

Blood Glucose Monitors
Insulin Delivery Devices
Continuous Glucose Monitoring Systems
Diabetes Management Software

Chemicals and Materials By End User (USD Billion, 2025-2035)

Hospitals
Homecare
Diabetes Clinics
Ambulatory Surgical Centers

Chemicals and Materials By Distribution Channel (USD Billion, 2025-2035)

Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
Direct Sales

Chemicals and Materials By Application (USD Billion, 2025-2035)

Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”